original ) (raw )Are GABAA Receptors Containing α5 Subunits Contributing to the Sedative Properties of Benzodiazepine Site Agonists?
Dubravko Bokonjic
Neuropsychopharmacology, 2008
View PDFchevron_right
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
Uwe Rudolph
Nature Reviews Drug Discovery, 2011
View PDFchevron_right
Determinants of recognition of ligands binding to benzodiazepine receptor/GABAA receptors initiating sedation
James Cook
European Journal of Pharmacology, 2000
View PDFchevron_right
Ionotropic GABA Receptors as Therapeutic Targets for Memory and Sleep Disorders
Jane Hanrahan
Annual Reports in Medicinal Chemistry, 2004
View PDFchevron_right
Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: The approximated activation of receptor subtypes may explain behavioral effects
Bojan Markovic
Brain Research, 2014
View PDFchevron_right
Gaba Receptors and Benzodiazepines
Colin Goodchild
BJA: British Journal of Anaesthesia, 1993
View PDFchevron_right
An Overview of the CNS-Pharmacodynamic Profiles of Nonselective and Selective GABA Agonists
Joop van Gerven
Advances in Pharmacological Sciences, 2012
View PDFchevron_right
Benzodiazepine Binding Site Occupancy by the Novel GABAA Receptor Subtype-Selective Drug 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H -1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b ]pyridazine (TPA023) in Rats, Primates, and Humans
Bindi Sohal
Journal of Pharmacology and Experimental Therapeutics, 2009
View PDFchevron_right
Anxiogenic properties of an inverse agonist selective for α 3 subunit-containing GABA A receptors
Neil Collinson
British Journal of Pharmacology, 2005
View PDFchevron_right
Characterization in Rats of the Anxiolytic Potential of ELB139 [1-(4-Chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a New Agonist at the Benzodiazepine Binding Site of the GABAA Receptor
Shahram Akbarzadeh
Journal of Pharmacology and Experimental Therapeutics, 2005
View PDFchevron_right
The Anxioselective Agent 7-(2-Chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) Is More Efficacious Than Diazepam at Enhancing GABA-Gated Currents at α1 Subunit-Containing GABAA Receptors
Martyna Krawczyk
Journal of Pharmacology and Experimental Therapeutics, 2006
View PDFchevron_right
Biological function of GABAA/benzodiazepine receptor heterogeneity
Hartmut Lüddens
Journal of Psychiatric Research, 1995
View PDFchevron_right
Tricyclic pyridones as functionally selective human GABAAα2/3 receptor-ion channel ligands
Andrew Owens
Bioorganic & Medicinal Chemistry Letters, 2004
View PDFchevron_right
Benzodiazepine Binding Site Occupancy by the Novel GABAA Receptor Subtype-Selective Drug 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine (TPA023) in Rats, Primates, and Humans
sandra sanabria
Journal of Pharmacology and Experimental Therapeutics, 2010
View PDFchevron_right
The Anxioselective Agent 7-(2-Chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) Is More Efficacious Than Diazepam at Enhancing GABA-Gated Currents at 1 Subunit-Containing GABAA Receptors
Phil Skolnick
Journal of Pharmacology and Experimental Therapeutics, 2006
View PDFchevron_right
The complexity of the GABAA receptor shapes unique pharmacological profiles
Frank Kooy
Drug Discovery Today, 2009
View PDFchevron_right
Computer-aided design of selective ligands of the benzodiazepine-binding site of the GABAA receptor
Vladimir Chupakhin
Doklady Chemistry, 2008
View PDFchevron_right
Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors
Neil Collinson
British journal of pharmacology, 2005
View PDFchevron_right
Faculty of 1000 evaluation for A Pharmacogenetic 'Restriction-of-Function' Approach Reveals Evidence for Anxiolytic-Like Actions Mediated by α5-Containing GABAA Receptors in Mice
Beverley Orser
F1000 - Post-publication peer review of the biomedical literature, 2016
View PDFchevron_right
GABAA and GABAB receptor agonists, partial agonists, antagonists and modulators: design and therapeutic prospects
Karla Frydenvang
European Journal of Pharmaceutical Sciences, 1997
View PDFchevron_right
Novel positive allosteric modulators of GABAA receptors: Do subtle differences in activity at α1 plus α5 versus α2 plus α3 subunits account for dissimilarities in behavioral effects in rats?
Shengming Huang
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010
View PDFchevron_right
Identification of amino acid residues responsible for the α5 subunit binding selectivity of L‐655,708, a benzodiazepine binding site ligand at the GABAA receptor
Karine Martin
Journal of …, 2001
View PDFchevron_right
Gabra5-gene haplotype block associated with behavioral properties of the full agonist benzodiazepine chlordiazepoxide
Yan Clément
Behavioural Brain Research, 2012
View PDFchevron_right
Regulation of GABAA receptor subunit expression by pharmacological agents
E. Korpi
Pharmacological Reviews, 2010
View PDFchevron_right
Actions of two GABAA receptor benzodiazepine-site ligands that are mediated via non-γ2-dependent modulation
Hartmut Lüddens
European Journal of Pharmacology, 2011
View PDFchevron_right
GABA receptors
Wolfgang Froestl
View PDFchevron_right